Amniotic Membrane and Its Derivatives: Novel Therapeutic Modalities in Liver Disorders

卷:12

Review

关键词: MESENCHYMAL STROMAL CELLS;    STEM-CELLS;    EPITHELIAL-CELLS;    ACTIVATED MACROPHAGES;    HEPATIC-FIBROSIS;    TISSUE;    TRANSPLANTATION;    DIFFERENTIATION;    MODEL;    MYOFIBROBLASTS;   

DOI  :  10.3390/cells12162114

来源: SCIE

【 摘 要 】

The liver is a vital organ responsible for metabolic and digestive functions, protein synthesis, detoxification, and numerous other necessary functions. Various acute, chronic, and neoplastic disorders affect the liver and hamper its biological functions. Most of the untreated liver diseases lead to inflammation and fibrosis which develop into cirrhosis. The human amniotic membrane (hAM), the innermost layer of the fetal placenta, is composed of multiple layers that include growth-factor rich basement membrane, epithelial and mesenchymal stromal cell layers. hAM possesses distinct beneficial anti-fibrotic, anti-inflammatory and pro-regenerative properties via the secretion of multiple potent trophic factors and/or direct differentiation into hepatic cells which place hAM-based therapies as potential therapeutic strategies for the treatment of chronic liver diseases. Decellularized hAM is also an ideal scaffold for liver tissue engineering as this biocompatible niche provides an excellent milieu for cell proliferation and hepatocytic differentiation. Therefore, the current review discusses the therapeutic potential of hAM and its derivatives in providing therapeutic solutions for liver pathologies including acute liver failure, metabolic disorders, liver fibrosis as well as its application in liver tissue engineering.